Innovative Solutions for Targeted Amplification in Next-Generation Sequencing

mmb · 07-26-2011, 05:02 PM

Talk at Drug Discovery & Diagnostic Development Week
Hyatt Regency San Francisco
Wednesday, Aug. 3
2:30pm - 3:00pm
http://www.ibclifesciences.com/Sequencing/agenda.xml

Streamlined Targeted Amplification for Next-Generation Sequencing Studies: Applications in Cancer Genomics

Next generation sequencing platforms have dramatically reduced sequencing costs. However, it currently remains too expensive to routinely resequence entire human genomes in order to discover genetic variants or somatic mutations underlying tumorigenesis. Therefore, a need exists for multiplexed, targeted amplification methods that allow for the analysis of multiple genomic regions in large cohorts. The novel microfluidic platform, the Access Array™ system enables just such research with minimal cost, time and sample material.

Andy May, Ph.D., Director, Next Generation Sequencing, Fluidigm
www.fluidigm.com

Similar Threads
Thread	Thread Starter	Forum	Replies	Last Post
Innovative Solutions vs AMPure	suefo	454 Pyrosequencing	2	10-14-2011 06:22 PM
PubMed: Targeted next-generation sequencing: microdroplet PCR approach for variant de	Newsbot!	Literature Watch	0	08-25-2011 11:10 AM
Building Next Generation Sequencing platforms and pipeline solutions	aurelielaugraud	Events / Conferences	6	10-23-2009 06:45 AM
Evaluation of next generation sequencing platforms for population targeted sequencing	div1982	Literature Watch	0	04-23-2009 07:39 AM
PubMed: Targeted next-generation sequencing by specific capture of multiple genomic l	Newsbot!	Literature Watch	3	12-02-2008 07:11 PM

07-26-2011, 05:02 PM	#1
mmb Junior Member Location: California Join Date: Jul 2011 Posts: 1	Innovative Solutions for Targeted Amplification in Next-Generation Sequencing Talk at Drug Discovery & Diagnostic Development Week Hyatt Regency San Francisco Wednesday, Aug. 3 2:30pm - 3:00pm http://www.ibclifesciences.com/Sequencing/agenda.xml Streamlined Targeted Amplification for Next-Generation Sequencing Studies: Applications in Cancer Genomics Next generation sequencing platforms have dramatically reduced sequencing costs. However, it currently remains too expensive to routinely resequence entire human genomes in order to discover genetic variants or somatic mutations underlying tumorigenesis. Therefore, a need exists for multiplexed, targeted amplification methods that allow for the analysis of multiple genomic regions in large cohorts. The novel microfluidic platform, the Access Array™ system enables just such research with minimal cost, time and sample material. Andy May, Ph.D., Director, Next Generation Sequencing, Fluidigm www.fluidigm.com